{{Distinguish|clonazepam|clonazolam|clorazolam}}
{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 5-(2-chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one
| image = Cloniprazepam.svg
| width = 175px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 
| CAS_supplemental = 
| class = [[Benzodiazepine]]s
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 
| UNII = 
| KEGG = 
| ChEBI = 
| ChEMBL = 
| synonyms = 1-Cyclopropylmethylclonazepam, Kloniprazepam, 2-Chloro-7'-nitroprazepam

<!--Chemical data-->
| C=19 | H=16 | Cl=1 | N=3 | O=3
| molecular_weight = 369.802 g/mol
| SMILES = O=C1N(CC2CC2)C3=CC=C([N+]([O-])=O)C=C3C(C4=CC=CC=C4Cl)=NC1
| StdInChI_Ref = 
| StdInChI = 1S/C19H16ClN3O3/c20-16-4-2-1-3-14(16)19-15-9-13(23(25)26)7-8-17(15)22(11-12-5-6-12)18(24)10-21-19/h1-4,7-9,12H,5-6,10-11H2
| StdInChIKey_Ref = 
| StdInChIKey = CCSYKGYLSFXNTA-UHFFFAOYSA-N
}}

'''Cloniprazepam''' is classified as a [[benzodiazepine]], it is a [[prodrug]] which is [[metabolized]] in the body into [[clonazepam]] and other [[metabolite]]s.<ref name="pmid27535017">{{cite journal|last1=Moosmann|first1=Bjoern|last2=Bisel|first2=Philippe|last3=Franz|first3=Florian|last4=Huppertz|first4=Laura M.|last5=Auwärter|first5=Volker|title=Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam|journal=Journal of Mass Spectrometry|date=November 2016|volume=51|issue=11|pages=1080–1089|doi=10.1002/jms.3840|pmid=27535017}}</ref> It is a [[designer drug]] (a "new psychoactive substance").<ref name="pmid27535017" />

==See Also==
* [[List of designer drugs]]
* [[List of benzodiazepines]]
* [[List of benzodiazepine designer drugs]]

==References==
{{Reflist|2}}

==External Links==
* https://www.unodc.org/LSS/Substance/Details/d115de07-ab8f-4454-a8f7-3ea15f4a0748
* http://nsddb.eu/substance/590/


{{GABAA receptor positive modulators}}
{{Benzodiazepines}}

[[Category:Anticonvulsants]]
[[Category:Anxiolytics]]
[[Category:Benzodiazepines]]
[[Category:Designer drugs]]
[[Category:Euphoriants]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Prodrugs]]


{{sedative-stub}}